Gregory A. Dorn - 18 Jul 2022 Form 3/A - Amendment Insider Report for CORVEL CORP (CRVL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3/A - Amendment
Accepted by SEC
04 Aug 2022, 20:40:16 UTC
Original report date
29 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sharon O'Connor, as Attorney-in-Fact for Gregory Dorn

Key filing fact

Gregory A. Dorn filed Form 3/A - Amendment for CORVEL CORP (CRVL) on 04 Aug 2022.

Key facts

  • This page summarizes Gregory A. Dorn's Form 3/A - Amendment filing for CORVEL CORP (CRVL).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 04 Aug 2022, 20:40.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
73
Date
18 Jul 2022
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16
Exercise price
$49.40
Footnotes
F1, F2
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
112
Exercise price
$52.69
Footnotes
F1, F2
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
800
Exercise price
$77.93
Footnotes
F1, F3
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
93
Exercise price
$87.49
Footnotes
F1, F2
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,400
Exercise price
$87.69
Footnotes
F1, F3
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
300
Exercise price
$119.48
Footnotes
F1, F2
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250
Exercise price
$148.89
Footnotes
F1, F2
CRVL holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000
Exercise price
$197.16
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Board of Directors of the Issuer has not determined that this employee qualifies as a "reporting person" for purposes of filing reports pursuant to Section 16(a) under the Securities Exchange Act of 1934, as amended. The original Form 3 was filed due to an administrative error.

Footnote F2

Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter.

Footnote F3

Option will vest based on achievement of certain performance criteria relating to earnings growth.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .